Advertisement

Index by author

January 01, 1985; Volume 27,Issue 1

A

  1. Allen, M

    1. The effect of tryptophan modification on the structure and function of a sea snake neurotoxin.
      M Allen and A T Tu
      Molecular Pharmacology January 1985, 27 (1) 79-85;

  2. Alm, G

    1. Fetal thymus organ culture as an in vitro model for the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners.
      L Dencker, E Hassoun, R d'Argy and G Alm
      Molecular Pharmacology January 1985, 27 (1) 133-140;

  3. Azari, J

    1. Export of cyclic AMP from avian red cells. Independence from major membrane transporters and specific inhibition by prostaglandin A.
      L E Heasley, J Azari and L L Brunton
      Molecular Pharmacology January 1985, 27 (1) 60-65;

B

  1. Bahouth, S W

    1. Specific binding of [3H-Tyr8]physalaemin to rat submaxillary gland substance P receptor.
      S W Bahouth, D M Lazaro, D E Brundish and J M Musacchio
      Molecular Pharmacology January 1985, 27 (1) 38-45;

  2. Batra, J K

    1. Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis.
      J K Batra, L Jurd and E Hamel
      Molecular Pharmacology January 1985, 27 (1) 94-102;

  3. Battistoni, C

    1. A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.
      L Cellai, S Cerrini, A Segre, C Battistoni, G Cossu, G Mattogno, M Brufani and E Marchi
      Molecular Pharmacology January 1985, 27 (1) 103-108;

  4. Bradford, P G

    1. Characterization of formylmethionyl-leucyl-phenylalanine stimulation of inositol trisphosphate accumulation in rabbit neutrophils.
      P G Bradford and R P Rubin
      Molecular Pharmacology January 1985, 27 (1) 74-78;

  5. Brufani, M

    1. A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.
      L Cellai, S Cerrini, A Segre, C Battistoni, G Cossu, G Mattogno, M Brufani and E Marchi
      Molecular Pharmacology January 1985, 27 (1) 103-108;

  6. Brundish, D E

    1. Specific binding of [3H-Tyr8]physalaemin to rat submaxillary gland substance P receptor.
      S W Bahouth, D M Lazaro, D E Brundish and J M Musacchio
      Molecular Pharmacology January 1985, 27 (1) 38-45;

  7. Brunton, L L

    1. Export of cyclic AMP from avian red cells. Independence from major membrane transporters and specific inhibition by prostaglandin A.
      L E Heasley, J Azari and L L Brunton
      Molecular Pharmacology January 1985, 27 (1) 60-65;

  8. Bulger, W H

    1. Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants.
      W H Bulger, V J Feil and D Kupfer
      Molecular Pharmacology January 1985, 27 (1) 115-124;

C

  1. Cellai, L

    1. A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.
      L Cellai, S Cerrini, A Segre, C Battistoni, G Cossu, G Mattogno, M Brufani and E Marchi
      Molecular Pharmacology January 1985, 27 (1) 103-108;

  2. Cerrini, S

    1. A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.
      L Cellai, S Cerrini, A Segre, C Battistoni, G Cossu, G Mattogno, M Brufani and E Marchi
      Molecular Pharmacology January 1985, 27 (1) 103-108;

  3. Chan, K K

    1. Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase.
      R G Moran, P D Colman, A Rosowsky, R A Forsch and K K Chan
      Molecular Pharmacology January 1985, 27 (1) 156-166;

  4. Colman, P D

    1. Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase.
      R G Moran, P D Colman, A Rosowsky, R A Forsch and K K Chan
      Molecular Pharmacology January 1985, 27 (1) 156-166;

  5. Contreras, R

    1. Use of artificial intelligence in structure-activity correlations of anticonvulsant drugs.
      G Klopman and R Contreras
      Molecular Pharmacology January 1985, 27 (1) 86-93;

  6. Cossu, G

    1. A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.
      L Cellai, S Cerrini, A Segre, C Battistoni, G Cossu, G Mattogno, M Brufani and E Marchi
      Molecular Pharmacology January 1985, 27 (1) 103-108;

D

  1. d'Argy, R

    1. Fetal thymus organ culture as an in vitro model for the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners.
      L Dencker, E Hassoun, R d'Argy and G Alm
      Molecular Pharmacology January 1985, 27 (1) 133-140;

  2. Dannan, G A

    1. Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes.
      A R Steward, G A Dannan, P S Guzelian and F P Guengerich
      Molecular Pharmacology January 1985, 27 (1) 125-132;

  3. Dencker, L

    1. Fetal thymus organ culture as an in vitro model for the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners.
      L Dencker, E Hassoun, R d'Argy and G Alm
      Molecular Pharmacology January 1985, 27 (1) 133-140;

E

  1. Ehrlich, Y H

    1. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
      R H Lenox, J Ellis, D Van Riper and Y H Ehrlich
      Molecular Pharmacology January 1985, 27 (1) 1-9;

  2. Eling, T E

    1. Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism.
      G A Reed, I O Griffin and T E Eling
      Molecular Pharmacology January 1985, 27 (1) 109-114;

  3. Ellis, J

    1. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
      R H Lenox, J Ellis, D Van Riper and Y H Ehrlich
      Molecular Pharmacology January 1985, 27 (1) 1-9;

  4. Enna, S J

    1. Characterization of the relationship between gamma-aminobutyric acid B agonists and transmitter-coupled cyclic nucleotide-generating systems in rat brain.
      E W Karbon and S J Enna
      Molecular Pharmacology January 1985, 27 (1) 53-59;

  5. Evans, T

    1. Guanine nucleotide-sensitive, high affinity binding of carbachol to muscarinic cholinergic receptors of 1321N1 astrocytoma cells is insensitive to pertussis toxin.
      T Evans, M W Martin, A R Hughes and T K Harden
      Molecular Pharmacology January 1985, 27 (1) 32-37;

F

  1. Feil, V J

    1. Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants.
      W H Bulger, V J Feil and D Kupfer
      Molecular Pharmacology January 1985, 27 (1) 115-124;

  2. Forsch, R A

    1. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
      A Rosowsky, R A Forsch, J Galivan, S S Susten and J H Freisheim
      Molecular Pharmacology January 1985, 27 (1) 141-147;
    2. Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase.
      R G Moran, P D Colman, A Rosowsky, R A Forsch and K K Chan
      Molecular Pharmacology January 1985, 27 (1) 156-166;

  3. Freisheim, J H

    1. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
      A Rosowsky, R A Forsch, J Galivan, S S Susten and J H Freisheim
      Molecular Pharmacology January 1985, 27 (1) 141-147;

G

  1. Galivan, J

    1. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
      A Rosowsky, R A Forsch, J Galivan, S S Susten and J H Freisheim
      Molecular Pharmacology January 1985, 27 (1) 141-147;

  2. Griffin, I O

    1. Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism.
      G A Reed, I O Griffin and T E Eling
      Molecular Pharmacology January 1985, 27 (1) 109-114;

  3. Guengerich, F P

    1. Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes.
      A R Steward, G A Dannan, P S Guzelian and F P Guengerich
      Molecular Pharmacology January 1985, 27 (1) 125-132;

  4. Guzelian, P S

    1. Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes.
      A R Steward, G A Dannan, P S Guzelian and F P Guengerich
      Molecular Pharmacology January 1985, 27 (1) 125-132;

H

  1. Hamel, E

    1. Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis.
      J K Batra, L Jurd and E Hamel
      Molecular Pharmacology January 1985, 27 (1) 94-102;

  2. Harden, T K

    1. Guanine nucleotide-sensitive, high affinity binding of carbachol to muscarinic cholinergic receptors of 1321N1 astrocytoma cells is insensitive to pertussis toxin.
      T Evans, M W Martin, A R Hughes and T K Harden
      Molecular Pharmacology January 1985, 27 (1) 32-37;

  3. Hassoun, E

    1. Fetal thymus organ culture as an in vitro model for the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners.
      L Dencker, E Hassoun, R d'Argy and G Alm
      Molecular Pharmacology January 1985, 27 (1) 133-140;

  4. Hauswirth, W W

    1. A method for assessing damage to mitochondrial DNA caused by radiation and epichlorohydrin.
      G Singh, W W Hauswirth, W E Ross and A H Neims
      Molecular Pharmacology January 1985, 27 (1) 167-170;

  5. Heasley, L E

    1. Export of cyclic AMP from avian red cells. Independence from major membrane transporters and specific inhibition by prostaglandin A.
      L E Heasley, J Azari and L L Brunton
      Molecular Pharmacology January 1985, 27 (1) 60-65;

  6. Hiller, J M

    1. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
      Y Itzhak, J M Hiller and E J Simon
      Molecular Pharmacology January 1985, 27 (1) 46-52;

  7. Hughes, A R

    1. Guanine nucleotide-sensitive, high affinity binding of carbachol to muscarinic cholinergic receptors of 1321N1 astrocytoma cells is insensitive to pertussis toxin.
      T Evans, M W Martin, A R Hughes and T K Harden
      Molecular Pharmacology January 1985, 27 (1) 32-37;

I

  1. Insel, P A

    1. A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta 1- and beta 2-adrenergic receptors.
      M D Snavely, M G Ziegler and P A Insel
      Molecular Pharmacology January 1985, 27 (1) 19-26;

  2. Itzhak, Y

    1. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
      Y Itzhak, J M Hiller and E J Simon
      Molecular Pharmacology January 1985, 27 (1) 46-52;

J

  1. Jurd, L

    1. Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis.
      J K Batra, L Jurd and E Hamel
      Molecular Pharmacology January 1985, 27 (1) 94-102;

K

  1. Karbon, E W

    1. Characterization of the relationship between gamma-aminobutyric acid B agonists and transmitter-coupled cyclic nucleotide-generating systems in rat brain.
      E W Karbon and S J Enna
      Molecular Pharmacology January 1985, 27 (1) 53-59;

  2. Klopman, G

    1. Use of artificial intelligence in structure-activity correlations of anticonvulsant drugs.
      G Klopman and R Contreras
      Molecular Pharmacology January 1985, 27 (1) 86-93;

  3. Kupfer, D

    1. Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants.
      W H Bulger, V J Feil and D Kupfer
      Molecular Pharmacology January 1985, 27 (1) 115-124;

L

  1. Laychock, S G

    1. Phosphatidylethanolamine N-methylation and insulin release in isolated pancreatic islets of the rat.
      S G Laychock
      Molecular Pharmacology January 1985, 27 (1) 66-73;

  2. Lazaro, D M

    1. Specific binding of [3H-Tyr8]physalaemin to rat submaxillary gland substance P receptor.
      S W Bahouth, D M Lazaro, D E Brundish and J M Musacchio
      Molecular Pharmacology January 1985, 27 (1) 38-45;

  3. Lenox, R H

    1. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
      R H Lenox, J Ellis, D Van Riper and Y H Ehrlich
      Molecular Pharmacology January 1985, 27 (1) 1-9;

M

  1. Marchi, E

    1. A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.
      L Cellai, S Cerrini, A Segre, C Battistoni, G Cossu, G Mattogno, M Brufani and E Marchi
      Molecular Pharmacology January 1985, 27 (1) 103-108;

  2. Marsh, J D

    1. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
      J D Marsh and T W Smith
      Molecular Pharmacology January 1985, 27 (1) 10-18;

  3. Martin, M W

    1. Guanine nucleotide-sensitive, high affinity binding of carbachol to muscarinic cholinergic receptors of 1321N1 astrocytoma cells is insensitive to pertussis toxin.
      T Evans, M W Martin, A R Hughes and T K Harden
      Molecular Pharmacology January 1985, 27 (1) 32-37;

  4. Mattogno, G

    1. A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.
      L Cellai, S Cerrini, A Segre, C Battistoni, G Cossu, G Mattogno, M Brufani and E Marchi
      Molecular Pharmacology January 1985, 27 (1) 103-108;

  5. Mohammad, S N

    1. A quantum mechanical approach to the theory of cancer from polynuclear compounds. Metabolic activation and carcinogenicity of extended anilines and aminoazo compounds.
      S N Mohammad
      Molecular Pharmacology January 1985, 27 (1) 148-155;

  6. Moran, R G

    1. Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase.
      R G Moran, P D Colman, A Rosowsky, R A Forsch and K K Chan
      Molecular Pharmacology January 1985, 27 (1) 156-166;

  7. Musacchio, J M

    1. Specific binding of [3H-Tyr8]physalaemin to rat submaxillary gland substance P receptor.
      S W Bahouth, D M Lazaro, D E Brundish and J M Musacchio
      Molecular Pharmacology January 1985, 27 (1) 38-45;

N

  1. Neims, A H

    1. A method for assessing damage to mitochondrial DNA caused by radiation and epichlorohydrin.
      G Singh, W W Hauswirth, W E Ross and A H Neims
      Molecular Pharmacology January 1985, 27 (1) 167-170;

R

  1. Reed, G A

    1. Inactivation of prostaglandin H synthase and prostacyclin synthase by phenylbutazone. Requirement for peroxidative metabolism.
      G A Reed, I O Griffin and T E Eling
      Molecular Pharmacology January 1985, 27 (1) 109-114;

  2. Rosowsky, A

    1. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
      A Rosowsky, R A Forsch, J Galivan, S S Susten and J H Freisheim
      Molecular Pharmacology January 1985, 27 (1) 141-147;
    2. Structural features of 4-amino antifolates required for substrate activity with mammalian folylpolyglutamate synthetase.
      R G Moran, P D Colman, A Rosowsky, R A Forsch and K K Chan
      Molecular Pharmacology January 1985, 27 (1) 156-166;

  3. Ross, W E

    1. A method for assessing damage to mitochondrial DNA caused by radiation and epichlorohydrin.
      G Singh, W W Hauswirth, W E Ross and A H Neims
      Molecular Pharmacology January 1985, 27 (1) 167-170;

  4. Rubin, R P

    1. Characterization of formylmethionyl-leucyl-phenylalanine stimulation of inositol trisphosphate accumulation in rabbit neutrophils.
      P G Bradford and R P Rubin
      Molecular Pharmacology January 1985, 27 (1) 74-78;

S

  1. Schreiber, G

    1. Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate. Different ligand-receptor conformations versus different receptor subclasses.
      G Schreiber and M Sokolovsky
      Molecular Pharmacology January 1985, 27 (1) 27-31;

  2. Segre, A

    1. A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.
      L Cellai, S Cerrini, A Segre, C Battistoni, G Cossu, G Mattogno, M Brufani and E Marchi
      Molecular Pharmacology January 1985, 27 (1) 103-108;

  3. Simon, E J

    1. Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes.
      Y Itzhak, J M Hiller and E J Simon
      Molecular Pharmacology January 1985, 27 (1) 46-52;

  4. Singh, G

    1. A method for assessing damage to mitochondrial DNA caused by radiation and epichlorohydrin.
      G Singh, W W Hauswirth, W E Ross and A H Neims
      Molecular Pharmacology January 1985, 27 (1) 167-170;

  5. Smith, T W

    1. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
      J D Marsh and T W Smith
      Molecular Pharmacology January 1985, 27 (1) 10-18;

  6. Snavely, M D

    1. A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta 1- and beta 2-adrenergic receptors.
      M D Snavely, M G Ziegler and P A Insel
      Molecular Pharmacology January 1985, 27 (1) 19-26;

  7. Sokolovsky, M

    1. Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate. Different ligand-receptor conformations versus different receptor subclasses.
      G Schreiber and M Sokolovsky
      Molecular Pharmacology January 1985, 27 (1) 27-31;

  8. Steward, A R

    1. Changes in the concentration of seven forms of cytochrome P-450 in primary cultures of adult rat hepatocytes.
      A R Steward, G A Dannan, P S Guzelian and F P Guengerich
      Molecular Pharmacology January 1985, 27 (1) 125-132;

  9. Susten, S S

    1. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
      A Rosowsky, R A Forsch, J Galivan, S S Susten and J H Freisheim
      Molecular Pharmacology January 1985, 27 (1) 141-147;

T

  1. Tu, A T

    1. The effect of tryptophan modification on the structure and function of a sea snake neurotoxin.
      M Allen and A T Tu
      Molecular Pharmacology January 1985, 27 (1) 79-85;

V

  1. Van Riper, D

    1. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
      R H Lenox, J Ellis, D Van Riper and Y H Ehrlich
      Molecular Pharmacology January 1985, 27 (1) 1-9;

Z

  1. Ziegler, M G

    1. A new approach to determine rates of receptor appearance and disappearance in vivo. Application to agonist-mediated down-regulation of rat renal cortical beta 1- and beta 2-adrenergic receptors.
      M D Snavely, M G Ziegler and P A Insel
      Molecular Pharmacology January 1985, 27 (1) 19-26;
Back to top

In this issue